Author

Alessandro Moretta

School of Medicine, University of Genova, Italy - Cited by 79,649 - Human Immunology

Biography

After earning his MD degree at the University of Genoa in 1978, he moved to the prestigious Ludwig Institute for Cancer research in Lausanne as a post-doctoral fellow.
Title
Cited by
Year
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...European journal of immunology 49 (10), 1457-1973, 2019201
1444
2019
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
S Pesce, M Greppi, G Tabellini, F Rampinelli, S Parolini, D Olive, ...Journal of Allergy and Clinical Immunology 139 (1), 335-346. e3, 2017201
390
2017
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion
F Locatelli, P Merli, D Pagliara, G Li Pira, M Falco, D Pende, R Rondelli, ...Blood, The Journal of the American Society of Hematology 130 (5), 677-685, 2017201
285
2017
Markers and function of human NK cells in normal and pathological conditions
G Del Zotto, E Marcenaro, P Vacca, S Sivori, D Pende, M Della Chiesa, ...Cytometry Part B: Clinical Cytometry 92 (2), 100-114, 2017201
139
2017
NK cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia
F Locatelli, D Pende, M Falco, M Della Chiesa, A Moretta, L MorettaTrends in immunology 39 (7), 577-590, 2018201
129
2018
Features of Memory-Like and PD-1+ Human NK Cell Subsets
M Della Chiesa, S Pesce, L Muccio, S Carlomagno, S Sivori, A Moretta, ...Frontiers in immunology 7, 351, 2016201
121
2016
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis
A Laroni, E Armentani, NK de Rosbo, F Ivaldi, E Marcenaro, S Sivori, ...Journal of autoimmunity 72, 8-18, 2016201
92
2016
NK cells, tumor cell transition, and tumor progression in solid malignancies: new hints for NK-based immunotherapy?
C Cantoni, L Huergo-Zapico, M Parodi, M Pedrazzi, MC Mingari, ...Journal of immunology research 2016, 2016201
80
2016
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
FR Mariotti, S Petrini, T Ingegnere, N Tumino, F Besi, F Scordamaglia, ...Oncoimmunology 8 (3), 1557030, 2019201
78
2019
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
S Gaggero, M Bruschi, A Petretto, M Parodi, GD Zotto, C Lavarello, ...Oncoimmunology 7 (9), e1470730, 2018201
67
2018
Human γδ T-cells: from surface receptors to the therapy of high-risk leukemias
V Pistoia, N Tumino, P Vacca, I Veneziani, A Moretta, F Locatelli, ...Frontiers in Immunology 9, 984, 2018201
57
2018
TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells
S Regis, F Caliendo, A Dondero, B Casu, F Romano, F Loiacono, ...Frontiers in Immunology 8, 868, 2017201
57
2017
Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells
G Pelizzo, V Veschi, M Mantelli, S Croce, V Di Benedetto, P D’Angelo, ...BMC cancer 18 (1), 1-12, 2018201
56
2018
Human NK cell subsets redistribution in pathological conditions: a role for CCR7 receptor
S Pesce, L Moretta, A Moretta, E MarcenaroFrontiers in immunology 7, 414, 2016201
47
2016
Human NK cells: From surface receptors to clinical applications
L Moretta, G Pietra, P Vacca, D Pende, F Moretta, A Bertaina, MC Mingari, ...Immunology letters 178, 15-19, 2016201
46
2016
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua
P Vacca, S Pesce, M Greppi, E Fulcheri, E Munari, D Olive, MC Mingari, ...Mucosal Immunology 12 (3), 624-631, 2019201
46
2019
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR-146a-5p in the regulation of KIR expression
S Pesce, M Squillario, M Greppi, F Loiacono, L Moretta, A Moretta, ...Frontiers in immunology 9, 2360, 2018201
43
2018
NKG2C+ memory‐like NK cells contribute to the control of HIV viremia during primary infection: Optiprim‐ANRS 147
F Gondois‐Rey, A Chéret, S Granjeaud, F Mallet, G Bidaut, C Lécuroux, ...Clinical & translational immunology 6 (7), e150, 2017201
43
2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A …
K Dobbs, G Tabellini, E Calzoni, O Patrizi, P Martinez, SC Giliani, ...Frontiers in immunology 8, 798, 2017201
43
2017
Cognate HLA absence in trans diminishes human NK cell education
V Landtwing, A Raykova, G Pezzino, V Béziat, E Marcenaro, C Graf, ...The Journal of Clinical Investigation 126 (10), 3772-3782, 2016201
42
2016

Referred From: https://scholar.google.it/citations?user=kMnk2QMAAAAJ&hl=it

Cited by
Citations 79649
h-index 148
i10-index 486
Recommended Journals
Open Access Journals